Setlur and colleagues identified a subtype of prostate cancer characterized by the fusion of the 5′-untranslated region of the androgen-regulated transmembrane protease serine 2 (TMPRSS2) promoter with erythroblast transformation-specific transcription factor family members (TMPRSS2-ER). This evidence concerns the gene TMPRSS2 and prostate cancer.